Adjuvant therapy for renal cell carcinoma

Overview of attention for article published in Journal of Cancer Metastasis and Treatment, January 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Readers on

mendeley: 8 Mendeley

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 4,351 followers.

RT @OAE_JCMT: ➡️A review on "Adjuvant therapy for renal cell carcinoma" 👨‍🏫Correspondence to: Dr. Hardev Pandha 🔗https://t.co/YE4CdOCqp5 @U…

#CancerTwitter #RCC #adjuvant #immunotherapy #prognosis 📢📢📢Don't miss this excellent article. https://t.co/iIrrDgEnxu @FaithfullProf @JonesAnnwen @AGovindarajanMD @docnrtiwari @QingZhangLab @AbigailMateos10 @pepeheffernan @ASanchez_PS @CameronAdlerMD @…

➡️A review on "Adjuvant therapy for renal cell carcinoma" 👨‍🏫Correspondence to: Dr. Hardev Pandha 🔗https://t.co/YE4CdOCqp5 @UniSurreyBioSci @RoyalSurrey @RSurreyResearch @grace_women @ChristinaUwins @Bhandoria https://t.co/vgtEE1BhmQ

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.